Dolomite Microfluidics, Sphere Fluidics Partner
News May 01, 2014
Sphere Fluidics and The Dolomite Centre Ltd. have now signed an exclusive distributor agreement for Sphere Fluidics' trademarked range of unique biochips, surfactants and other specialist chemicals for picodroplet applications. These will be promoted and sold via Dolomite’s worldwide sales channels.
Dr Robert Marchmont, Commercial Director of Sphere Fluidics, stated: “We are very impressed with Dolomite’s technical, manufacturing and commercial expertise in the area of microfluidics and are now pleased to strengthen our current relationship with this new agreement. Specifically, we see great synergy between our scientific development and their Productizing Science® skills and sales & marketing reach. We are looking forward to further growing our successful partnership.” Mr Lee Jeffries, COO of Dolomite, said: “Picodroplets are a fascinating and fast growing area of research, especially useful where tests need to be conducted on picolitres of sample containing, for example, single cells or biologically-important molecules. Sphere Fluidics’ scientific know-how and capability in the core areas of picodroplet based technology will enable Dolomite to enhance our market leading microfluidic system solutions, by offering unique capabilities in picodroplet generation, isolation and analysis.”
Restoring the ability to walk following spinal cord injury requires neurons in the brain to reestablish communication pathways with neurons in the spinal cord, Mature neurons, however, are unable to regenerate their axons to facilitate this process. New research in mice shows one potential route to overcome this limitation may be by targeting liver kinase B1 (LKB1) protein.
International Conference on Cell and Structural biology
Jul 15 - Jul 16, 2019